Consent given pursuant to sections 14 and 14A for the supply and importation of the Therapeutic Goods specified subject to conditions specified - between 28 October 2011 and 6 February 2012

Administered by Department of Health, Disability and Ageing

Legislation au C2014G00043 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

Department of Health
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

Section 14 and 14a Notice

 

Between 28th October 2011 and 6th February 2012, the delegate of the Secretary of the Department of Health and Ageing gave consent pursuant to sections 14 and 14A of the Therapeutic Goods Act 1989 (the Act) to the following:

  1. The supply, importation of the therapeutic goods or classes of therapeutic goods specified in Column 2 of the Table and with the Australian Register of Therapeutic Goods number (ARTG No.) specified in Column 3 of the Table; and
  2. Without conforming to those clauses, specified in Column 5 of the Table, of the standard, specified in the Column 4 of the Table otherwise applicable to the goods.

Pursuant to section 15(1) of the Act, consent is subject to the conditions specified in Column 6 of the Table and consent is given for the period specified in Column 7 of the Table, provided all other requirements of the standard are met.

Column 1

Column 2

Column 3

Column 4

Column5

Column 6

Column 7

Sponsor

Goods or Classes of Goods

ARTG No.

Standard

Clause

Conditions

Period for which consent is given

Health World Limited

Ethic Nutrients Immune Defence

189795

TGO 69

3 (2)(g)

The goods may be supplied with a label that does not include the label statements required by Required Advisory Statements for Medicine Labels in relation to products containing vitamin A that are intended for use by adults, provided the following condition are met:

-                The label includes the advisory statement ‘Warning: If pregnant or considering becoming pregnant consult your healthcare practioner before taking vitamin A as when in excess of 3000 µg RE for women and 900 µg RE for men’;

-                The label includes statements that “µg = micrograms” and “RE = retinol equivalents”; and,

-                all other requirements of the Order are met.

Until Further Notice

Sanofi-Aventis Healthcare Pty Ltd

Golden Glow Men’s One a day Multivitamin

191120

TGO 69

3 (2)(g)

The sponsor may supply, import or export the goods with a product label that does not included the Required Advisory Statement for Medicine Labels (RASML) statements 32 and 33, as outlined below:

a)                 ‘Warning – When taken in excess of 3000 micrograms retinol equivalents, vitamin A can cause birth defects.’

‘If you are pregnant, or considering becoming pregnant, do not take vitamin A supplements without consulting your doctor or pharmacist.’

Along with consent for the sponsor to supply, import or export the goods with label that includes the abridged version of RASML statement 31:

‘The recommended daily amount of vitamin A from all sources is 900 micrograms retinol equivalent for men’

Until further notice

Bausch & Lomb Australia Pty Ltd

Ocuvite Adult 50+

189300

TGO 78

10 (b)

The upper limit in the goods of:

i)            lutein is not more than 135% of the stated content, rather than the required 120%, and,

ii)          Zeaxanthin is not more than 190% of the stated content, rather than the required 120%

Until Further Notice

Integria Healthcare

Thompson’s B5 500mg

114599

TGO78

10(d)

Batch Number 1112063, the disintegration time for the tablets is not more than 27 minutes, rather than 15 minutes as required by the British Pharmacopoeia general monograph for tablets

Until further notice

BioMedica Nutraceuticals Pty Ltd

UltraLiv

175153

TGO 78

9 (2)

The product is not required to comply with the dissolution requirements for folic acid of the United States Pharmacopeia-National Formulary, chapter <2040> “Disintegration and Dissolution of Dietary Supplements”.

Until 17 January 2014

Nu Skin Enterprises Australia Inc

LifePak Prime

&

LifePak

174610

 

&

176310

TGO 69

3(12)(b)

The requirements specified in subclauses 3(2)(b) and (c), that the names and quantity of the active ingredients in the goods are not required to appear on the individual sachet label, provided that all other requirements are met.

Until further notice

Swisse Vitamins Pty Ltd

Swisse Men’s Ultivite Multivitamin, Mineral & Antioxidant with Herbs 50+ Years (Tablets)

1690721

TGO 69

3(2)(g)

The sponsor may supply, import or export the goods with a product label that does not included the Required Advisory Statement for Medicine Labels (RASML) statements 32 and 33, as outlined below:

b)                 ‘Warning – When taken in excess of 3000 micrograms retinol equivalents, vitamin A can cause birth defects.’

c)                 ‘If you are pregnant, or considering becoming pregnant, do not take vitamin A supplements without consulting your doctor or pharmacist.’

Until further notice

Swisse Men’s Ultivite Multivitamin Mineral & Antioxidant with Herbs No Iron Iodine

169034

Swisse Men’s Ultivite 65+ Multivitamin, Mineral Antioxidant with Herbs

187229

Swisse Practioner Men’s Ultivite

193887

Swisse Professional Men’s Ultivite-B

189987

Swisse Ultivite Women’s 65+ Multivitamin, Mineral & Antioxidant with herbs

179193

 

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.